Knight Therapeutics Inc. sees positive stock movement amid recent developments.
Knight Therapeutics Inc. (GUD.TO) has seen a slight increase in its stock price this week, reflecting positive investor sentiment following various corporate announcements. In the latest trading session, the stock closed at C$9.63, up 0.92% for the day and 5.71% over the week.
Advertisement
Knight Therapeutics Inc.
GUD.TO
GUD.TO
Knight Therapeutics Inc.
WealthAwesomeMarket cap
$955.79M
P/E
64.9x
52W high
$10.17
52W low
$5.66
1W change
+5.71%
Beta
0.05
Analyst Price Targets
Based on analyst covering GUD
Wall Street analysts forecast GUD stock price to rise 10.3% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$10.83
+10.3% Upside
Current Price
C$9.82
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GUD's historical volatility
30-Day Vol
32.7%
Annualized
90-Day Vol
32.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$11.74
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.42 | C$9.31 – C$11.67 |
| 60 trading days | C$11.06 | C$9.43 – C$12.98 |
| 90 trading days | C$11.74 | C$9.65 – C$14.28 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Knight Therapeutics' recent corporate activities and financial performance, as these may impact future stock performance. The company’s strategic decisions and market positioning could significantly influence its growth trajectory.
Knight Therapeutics Sees 66.16% Year-to-Date Growth
The stock has shown strong growth this year, indicating significant market interest and potential for continued improvement.
Bull case
Recent financial results and strategic acquisitions may boost investor confidence, suggesting a positive outlook for the company.
Bear case
Despite recent gains, concerns about profitability and overall market conditions could affect investor sentiment.
Recent Price Action
Knight Therapeutics Inc. has seen its stock price rise to C$9.63, reflecting a 0.92% increase in the latest trading session. Over the past week, the stock has appreciated by 5.71%. Year-to-date, Knight Therapeutics has delivered a substantial return of 66.16%, showcasing strong investor interest.
Catalysts Behind the Movement
Advertisement
The stock's recent performance is linked to several corporate announcements. Knight Therapeutics reported its Q2 2026 financial results, revealing revenues of $144,212, a 34% increase from the previous year, along with an adjusted EBITDA of $52 million. Additionally, the company filed an early warning report regarding its holdings in Crescita Therapeutics and amended its normal course issuer bid to increase the maximum number of shares it plans to repurchase. These developments indicate a proactive approach to managing capital and expanding market presence.
Technical Picture
From a technical perspective, Knight Therapeutics is currently trading slightly above its 50-day moving average of C$9.60, suggesting a positive short-term trend. The stock also remains well above its 200-day moving average of C$7.41, reflecting strong long-term performance. The 52-week range for GUD.TO is C$5.66 to C$10.17, with the current price at about 88% of that range. The stock's beta of 0.05 indicates low volatility compared to the broader market, which may attract risk-averse investors.
Insider Activity
Currently, there are no recent insider trading activities reported for Knight Therapeutics, which may suggest stable management confidence in the company's direction.
Final Thoughts
With a last close of C$9.63, Knight Therapeutics Inc. has shown resilience and growth potential. Investors should consider the company's recent performance and strategic initiatives when evaluating future opportunities.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
